Cipla Limited (CIPLA) — Corporate Action | 31 July 2026
Cipla announced the allotment of 7,850 fully paid-up equity shares of INR 2 each under its ESOS 2013-A and Cipla ESAR Scheme 2021, increasing the paid-up share capital to INR 1,61,57,06,332 comprising 80,78,53,166 shares of INR 2 each.
About Cipla Limited (CIPLA)
Healthcare · Pharmaceuticals & Biotechnology · Listed on NSE
📡 Get AI alerts when CIPLA files next
Free • Daily 5 PM digest • Track filings, board meetings, and corporate actions
Track CIPLA — Free💡 Ask AI about this filing
📊 More CIPLA filings
- Announcement — 27 July 2026 Cipla announced U.S. FDA approval for its generic version of Advair Diskus across all three strength...
- 🔴 Financial Results — 23 July 2026 Cipla reported consolidated revenue of INR 7,119 crores for Q1 FY27, up 2% YoY, with One India busin...
- 🟡 Board Meeting — 23 July 2026 Cipla announced that Sanjay Joseph, Head of API Business, will cease to be a Senior Management Perso...
- 🟡 Board Meeting — 23 July 2026 Cipla announced board approval of key managerial personnel changes effective 24 July 2026, including...
- 🟡 Board Meeting — 23 July 2026 Cipla announced board-approved succession in its finance leadership: Ashish Adukia stepped down as G...
🔥 Also filed on 31 July 2026
Source: Stock Announcements. Analysis by StockFin.ai. For informational purposes only — not investment advice.
Editorial & Data Transparency Notice
This analysis was programmatically compiled using StockFin AI utilizing official regulatory disclosures from the BSE and NSE. Content is automatically synthesized and audited against public financial filings. StockFin.ai is an educational research platform and is NOT a SEBI-registered investment advisor or research analyst.
📡 Get AI alerts when CIPLA files new disclosures
Track CIPLA filings, board meetings, and corporate actions. Free email alerts at 5 PM.
Track CIPLA — FreeFree account · 2 AI queries/day
© 2026 StockFin.ai — AI-powered Indian stock research